arBtrage CAPITALIZING MARKETS checking… Sign in Sign up

Aclaris Therapeutics, Inc.

ACRS Health Care Biotechnology: Pharmaceutical Preparations
$4.36
▼ -7.4% Today
as of Jun 7, 07:08 ET
Last 30 days +3.32% Apr 28 → Jun 05
$4.15 $4.40 $4.65 $4.91 $5.16 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$4.69
High
$4.70
Low
$4.33
Volume
$928,845
Avg Vol
$2M
Mkt Cap
$638M
P/E (TTM)
Beta
52w High
$5.15
52w Low
$1.34
Div Yield
Shares Out
$140M

Overview

52-week range
$1.34
$5.15
79% of range
Avg surprise (last 2)
+17.8%
Avg reaction (last 2)
+3.2%
100% positive
Latest IV / EM
166%
EM ±22.9% · $4 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.42$-0.34$-0.27$-0.19$-0.11 Actual $-0.42Actual $-0.41Actual $-0.24Actual $-0.15Actual $-0.11Actual $-0.12Est $-0.17Actual $-0.13Actual $-0.12Actual $-0.15Est $-0.16 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-20M$-17M$-14M$-11M$-8M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Thu May 7, 2026Mar/2026 $-0.15 $-0.16 +6.2% -25.0% +1.7% earnings
Tue Sep 30, 2025Sep 2025 $-0.12 financials
Mon Jun 30, 2025Jun 2025 $-0.13 financials
Thu May 8, 2025Mar/2025 $-0.12 $-0.17 +29.4% +4.8% earnings
Mon Sep 30, 2024Sep 2024 $-0.11 financials
Sun Jun 30, 2024Jun 2024 $-0.15 financials
Sun Mar 31, 2024Mar 2024 $-0.24 financials
Sat Sep 30, 2023Sep 2023 $-0.41 financials
Fri Jun 30, 2023Jun 2023 $-0.42 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue
Cost of revenue$395,000$538,000$515,000$506,000$654,000$624,000
Gross profit
Operating income$-22M$-17M$-18M$-18M$-10M$-13M
Net income$-20M$-15M$-15M$-15M$-8M$-11M
EPS (diluted)$-0.15$-0.12$-0.13$-0.12$-0.11$-0.15

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$29M$20M$25M$25M$30M$25M$48M$23M
Inventory
Total current assets$110M$96M$101M$104M$109M$126M$132M$118M
Total assets$199M$160M$176M$189M$198M$220M$182M$161M
Long-term debt
Total liabilities$55M$57M$55M$57M$54M$65M$52M$27M
Total equity$144M$103M$120M$132M$144M$156M$130M$134M

Implied volatility — last 90 days

160%163%165%168%170% Jun 07 — IV 166% · EM ±22.9%

Sector peers

🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.